A Randomized, Double-blind, Multi-center, Phase 3 Trial to Evaluate the Efficacy and Safety of a Fixed Dose Combination of S-Amlodipine and Telmisartan CKD-828) Versus S-Amlodipine Monotherapy in Hypertensive Patients Inadequately Controlled by S-Amlodipine Monotherapy.
Phase of Trial: Phase III
Latest Information Update: 12 Nov 2012
At a glance
- Drugs Levamlodipine/telmisartan (Primary) ; Levamlodipine
- Indications Essential hypertension
- Focus Therapeutic Use
- 26 Sep 2012 Status changed from recruiting to completed as reported by Korean Clinical Trials Register record.
- 15 Feb 2012 New source identified and integrated (Clinical Research Information Service (CriS) - Republic of Korea; KCT0000321).
- 04 Jan 2012 New trial record